Bronchopulmonary dysplasia is not related to neurofilament light for neuroaxonal damage in preterm infants.
Michelle RomijnEmma M BaasBirgit I Lissenberg-WitteWes OnlandMarsh KönigsJaap OosterlaanHans HeijstJoost RotteveelAnton H van KaamCharlotte E TeunissenMartijn J J FinkenPublished in: Pediatric research (2022)
Neurofilament light chain (NfL) is a known biomarker for neuroaxonal damage. Biomarkers for brain damage during the first weeks of life in preterm infants developing BPD are lacking. NfL levels obtained during the first weeks of life did not differ between infants with and without BPD in analyses adjusted for GA, SGA, and IVH.